{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-childhood/management/children-up-to-1-year-of-age/","result":{"pageContext":{"chapter":{"id":"75d2baa6-d689-537b-985d-3b2b1c30e8b3","slug":"children-up-to-1-year-of-age","fullItemName":"Scenario: Children up to 1 year of age","depth":2,"htmlHeader":"<!-- begin field 0fe8a76a-e77d-48f2-aa18-448036d067cd --><h2>Scenario: Childhood immunizations - up to 1 year of age</h2><!-- end field 0fe8a76a-e77d-48f2-aa18-448036d067cd -->","summary":"Covers the vaccination of healthy children from two months of age up to their first birthday.","htmlStringContent":"<!-- begin item 96d9519c-ca11-478b-bb97-2d2951570fe5 --><!-- begin field 9bc56f05-461e-4626-89c5-acbd008874cc --><p>From age 2 months to 25 years.</p><!-- end field 9bc56f05-461e-4626-89c5-acbd008874cc --><!-- end item 96d9519c-ca11-478b-bb97-2d2951570fe5 -->","topic":{"id":"141a79f8-bf34-5bd6-9d3e-4e2d2e1c98f3","topicId":"884b0998-c242-4b76-869c-7e1d7203ac34","topicName":"Immunizations - childhood","slug":"immunizations-childhood","lastRevised":"Last revised in November 2020","chapters":[{"id":"6ba54a01-de23-5846-8b4d-e24477c75832","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ca5ebce-3bb6-51f5-897f-9f02d913dd37","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"69eb6e91-b113-53eb-bd4e-6a2f49ca6593","slug":"changes","fullItemName":"Changes"},{"id":"0b393c87-257a-567c-b12f-c3d1f55b13aa","slug":"update","fullItemName":"Update"}]},{"id":"ea1bc6cb-f5cf-5581-8659-301af7d9fb67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f586895e-7f2d-51ef-baa8-6a9a1e98695f","slug":"goals","fullItemName":"Goals"},{"id":"1420f7f8-09c4-58fa-8d52-9b4a3d2a8ddf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"16ddc68d-be0a-56cd-b38a-9acdf13a0bfe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"713a5cac-cd5d-58d0-8793-b453d244027d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a6ab4abc-1ddb-5864-9f72-3eb58c16089a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b3ef6d84-ce51-57df-ba8a-40fbd3b7ceee","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e9c4eca9-e338-5ae7-9ad6-cffd74ef6c52","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9a89a8f0-b573-5292-93a2-1ee7ba24d67e","slug":"the-routine-childhood-immunization-schedule","fullItemName":"The routine childhood immunization schedule"},{"id":"fffdcf61-8f20-593c-9fbc-a4de125dab35","slug":"childhood-immunization-programme-coverage","fullItemName":"Childhood immunization programme coverage"}]},{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","fullItemName":"Management","slug":"management","subChapters":[{"id":"75d2baa6-d689-537b-985d-3b2b1c30e8b3","slug":"children-up-to-1-year-of-age","fullItemName":"Scenario: Children up to 1 year of age"},{"id":"cb326e70-51cb-5b55-86a4-5d1f28fbcf08","slug":"children-1-2-years-of-age","fullItemName":"Scenario: Children 1-2 years of age"},{"id":"6b4cbafe-fdfb-583a-a3fe-7a96b10253c4","slug":"children-2-10-years-of-age","fullItemName":"Scenario: Children 2-10 years of age"},{"id":"88a19f4f-827e-5331-836f-99c46181a1f9","slug":"children-over-10-years-of-age","fullItemName":"Scenario: Children over 10 years of age"},{"id":"df573b46-28ae-516a-adde-90b8bc742b29","slug":"additional-immunizations","fullItemName":"Scenario: Additional immunizations"}]},{"id":"3a2ea091-53a4-51b4-8c1b-16bbc187300b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39c5bd91-68df-5d37-bdf6-a3fbf4194d8b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e5eea053-f5bc-5745-955b-0200236a454a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8546e676-a44d-5c1d-a1b9-5d571b466524","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b8c8a42-fd07-546b-8ec8-59db2829b422","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"913a73f4-d332-5491-a242-fb9e5fed1e37","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8e7e3dc1-7bda-57e5-ba9b-f03e0049b730","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d5fbf31a-ca3a-5b16-86c7-90949cade220","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"6aa3e32a-65b5-500d-94fc-c557d9f24fc1","slug":"immunization-schedule","fullItemName":"Immunization schedule","depth":3,"htmlHeader":"<!-- begin field 566c471e-c668-430e-8d7a-5f788333ec40 --><h3>What is the immunization schedule for children younger than 1 year of age?</h3><!-- end field 566c471e-c668-430e-8d7a-5f788333ec40 -->","summary":null,"htmlStringContent":"<!-- begin item 1c779327-e3b5-4146-aac3-b193307128a5 --><!-- begin field c9d38244-961c-4143-8b5b-fe7ececcf5b6 --><ul><li><strong>At 8 weeks of age</strong> — one dose of vaccine for diphtheria, tetanus, pertussis, polio, <em>Haemophilus influenzae</em> type b and hepatitis B vaccine (DTaP/IPV/Hib/HepB - Infanrix hexa<sup>®</sup>); one dose of meningococcal group B disease (MenB) vaccine (MenB — Bexsero<sup>®</sup>); and one dose of rotavirus vaccine (Rotarix<sup>®</sup>).</li><li><strong>At 12 weeks of age</strong> — one dose of DTaP/IPV/Hib/HepB; one dose of pneumococcal conjugate vaccine (PCV — Prevenar 13<sup>®</sup>); and one dose of rotavirus vaccine.</li><li><strong>At 16 weeks of age</strong> — one dose of DTaP/IPV/Hib/HepB, and one dose of MenB vaccine.</li><li><strong>Note:</strong> There are now two potential variations in administering MenB vaccines.<ul><li>The Men B dosing schedule is either three doses of 0.5 ml with an interval of not less than 1 month, or two doses of 0.5 ml with an interval of not less than 2 months.</li></ul></li></ul><!-- end field c9d38244-961c-4143-8b5b-fe7ececcf5b6 --><!-- end item 1c779327-e3b5-4146-aac3-b193307128a5 -->","subChapters":[{"id":"9f938f36-a298-5c61-94e4-b75cf46768ae","slug":"basis-for-recommendation-084","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c299c772-bda0-4c44-bf8a-1675f8282161 --><h4>Basis for recommendation</h4><!-- end field c299c772-bda0-4c44-bf8a-1675f8282161 -->","summary":null,"htmlStringContent":"<!-- begin item 084ab1b6-2f23-4576-bd76-06874f02e901 --><!-- begin field 735987ae-6fa8-4dcf-9898-401dbb0d243f --><p>These recommendations are based on the Public Health England (PHE) documents<em> Routine childhood immunisations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016e</a>], <em>The routine immunisation schedule [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2020</a>]</em>, <em>Hexavalent combination vaccine: programme guidance, 2017</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2017</a>], the PHE letter <em>Changes to the infant pneumococcal conjugate vaccine schedule </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2019a</a>], and Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI, 2020</a>]. </p><!-- end field 735987ae-6fa8-4dcf-9898-401dbb0d243f --><!-- end item 084ab1b6-2f23-4576-bd76-06874f02e901 -->","subChapters":[]}]},{"id":"cbbcc9ea-3d65-52a2-aaa5-140f8503b04d","slug":"advice-for-parents","fullItemName":"Advice for parents","depth":3,"htmlHeader":"<!-- begin field cf7c5592-7cd7-4c5e-a3b9-ea0bbc338108 --><h3>What advice should I give to parents or carers of children younger than 1 year of age?</h3><!-- end field cf7c5592-7cd7-4c5e-a3b9-ea0bbc338108 -->","summary":null,"htmlStringContent":"<!-- begin item 6d58e8f4-d56d-44c1-9ffe-e0d8ad78d7e6 --><!-- begin field 2bb9b205-413e-4dad-aaba-ff63943d5dfd --><ul><li><strong>Explain the benefits of vaccination,</strong> in particular, that it helps prevent serious illness in children, especially potentially severe disease such as meningitis, whooping cough, and tetanus. <ul><li>Information about <a href=\"https://www.nhs.uk/conditions/vaccinations/\" data-hyperlink-id=\"2c7b7003-87dd-4c85-9ff0-aa5600e2ee94\">vaccinations</a> (including the UK childhood immunization schedule, vaccine safety, risks and benefits, and individual vaccines) is available on the <a data-hyperlink-id=\"c3b40465-b563-439f-96d1-a8f7014b21a5\" href=\"https://www.nhs.uk/conditions/\">NHS </a>website.</li></ul></li><li><strong>Reassure that vaccinations are safe,</strong> and serious adverse effects are very rare. Pain, swelling, and reddening at the site of injection are most common and systemic adverse effects, should they occur, are usually limited to mild fever.</li><li><strong>The </strong><strong>infanrix</strong><strong> vaccine </strong>may contain traces of neomycin, polymyxin and polysorbate 80 which are used during the manufacturing process, in children who have a hypersensitivity the vaccine is contra-indicated.</li><li><strong>Advise parents or carers not to routinely give paracetamol or ibuprofen to prevent fever</strong> around the time of vaccination unless the meningitis B (MenB) vaccine (Bexsero<sup>®</sup>) is being given. However, if pain or fever is problematic <em>after</em> the child has been vaccinated, then paracetamol or ibuprofen may be used. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.</li><li><strong>If the MenB vaccine (Bexsero<sup>®</sup>) is being given</strong> as part of the routine immunization schedule, advise the parent/carer to administer oral infant paracetamol suspension (120 mg/5 mL) to infants up to 6 months of age. For most babies, advise the following dosing schedule (be aware that the suggested dosage schedule is outside the current paracetamol licence):<ul><li>Dose 1 — 2.5 mL (60 mg) as soon as possible after vaccination.</li><li>Dose 2 — 2.5 mL (60 mg) 4–6 hours after the first dose.</li><li>Dose 3 — 2.5 mL (60 mg) 4–6 hours after the second dose.</li></ul></li><li>If the infant was born at less than 32 weeks' gestation and currently weighs less than 4 kg, prescribe paracetamol according to their weight at the time of immunization. For more information, see the <a data-hyperlink-id=\"0be24d9d-f1db-4a90-9a1f-a8f7014b21fa\" href=\"http://www.evidence.nhs.uk/formulary/bnfc/current\">British National Formulary for Children</a>.</li><li><strong>Offer parents or carers written information,</strong> such as the Public Health England patient information leaflets <a data-hyperlink-id=\"926fcb9b-ddbb-42f9-8139-a8f7014b21fe\" href=\"https://www.gov.uk/government/publications/what-to-expect-after-vaccinations\">What to expect after vaccinations</a>, <a data-hyperlink-id=\"5db6ec07-2de1-47dc-994c-a8f7014b222d\" href=\"https://www.gov.uk/government/publications/menb-vaccine-and-paracetamol\">Using paracetamol to prevent and treat fever after MenB vaccination</a> and <a data-hyperlink-id=\"ebcf2099-aaa1-4f60-9604-a8f7014b2232\" href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/543379/9867_MMR_A5leaflet.pdf\">MMR vaccination</a>. The leaflet <a data-hyperlink-id=\"1c175fda-98d8-4099-b58f-a8f7014b2252\" href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/525375/MenC_flyer_for_parents_to_explain_the_schedule_change_May16.pdf\">MenC vaccination programme</a> may also be useful to explain recent changes to the meningitis C (MenC) vaccination programme.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI, 2018</a>]</p><!-- end field 2bb9b205-413e-4dad-aaba-ff63943d5dfd --><!-- end item 6d58e8f4-d56d-44c1-9ffe-e0d8ad78d7e6 -->","subChapters":[{"id":"1e12c8bd-0b5c-5a61-a765-ccde9fe2e76b","slug":"basis-for-recommendation-769","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f0506589-9084-499a-9634-8e3f9e2559d5 --><h4>Basis for recommendation</h4><!-- end field f0506589-9084-499a-9634-8e3f9e2559d5 -->","summary":null,"htmlStringContent":"<!-- begin item 76949a21-299c-4878-8938-e218a2177a3c --><!-- begin field d3fac932-c477-438c-babb-12b973203666 --><p>The recommendations on advice to give to parents and carers are based on information in the chapter on vaccine safety and adverse effects following immunization in <em>Immunisation against infectious disease</em> (the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>], published by Public Health England (PHE) and are pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Explaining the benefits of vaccination</h5><ul><li>Many parents find the process of having their children immunized distressing. Explaining the benefits of vaccination and giving reassurance about the limited nature of any adverse effects should be helpful.</li></ul><h5>Use of paracetamol or ibuprofen</h5><ul><li>CKS found no controlled trials on the efficacy of paracetamol or ibuprofen in reducing pain or fever following vaccination.<ul><li>As paracetamol and ibuprofen have been shown to reduce fever and pain in conditions such as the common cold and influenza [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">Eccles, 2006</a>], it can be reasonably extrapolated that they may be effective in relieving these symptoms on an 'as required' basis after vaccination.</li></ul></li><li>PHE recommends that paracetamol or ibuprofen should not be routinely given to prevent fever in children who receive vaccinations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>]. It states that there is no evidence that paracetamol or ibuprofen prevent febrile convulsions and that there is some evidence that they may lower antibody responses to some vaccines when given around the time of vaccination [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">Prymula et al, 2009</a>]. However, subsequently, in relation to the meningitis B (MenB) vaccine (Bexsero<sup>®</sup>):<ul><li>The Joint Committee on Vaccination and Immunisation (JCVI) and PHE acknowledge the results of clinical trials suggesting an increase in the frequency of fever following routine immunizations when Bexsero<sup>®</sup> was given with other routine childhood vaccines. It was found that prophylactic paracetamol reduced fever rates without having a significant effect on the immune response [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">JCVI, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016f</a>].</li><li>The JCVI therefore recommends three doses of paracetamol for infants being immunized with Bexsero<sup>®</sup> at 2 and 4 months of age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016f</a>]. The manufacturer's Summary of Product Characteristics for Bexsero<sup>®</sup> also states that prophylactic administration of antipyretics at the time of, and closely after, vaccination can reduce the incidence and intensity of post-vaccination febrile reactions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">ABPI Medicines Compendium, 2015a</a>].</li><li>The paracetamol dosing schedule, including the recommendation for preterm infants, reflects that provided by the JCVI and PHE and is supported by the Commission on Human Medicines (despite the suggested dosing schedule being outside the licence for paracetamol) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015i</a>],<strong><em> </em></strong>information for healthcare professionals from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016f</a>], and NHS patient information provided by PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015j</a>].</li></ul></li></ul><!-- end field d3fac932-c477-438c-babb-12b973203666 --><!-- end item 76949a21-299c-4878-8938-e218a2177a3c -->","subChapters":[]}]},{"id":"c9ac4124-dbd8-5029-9f46-335454cbd4ee","slug":"missed-doses","fullItemName":"Missed doses","depth":3,"htmlHeader":"<!-- begin field 1cd4c612-988c-4c61-a85c-1eea303c93b9 --><h3>What should I do if a child younger than 1 year of age has missed doses?</h3><!-- end field 1cd4c612-988c-4c61-a85c-1eea303c93b9 -->","summary":null,"htmlStringContent":"<!-- begin item 0a909ee8-a5e1-4926-8751-bdebb9e2b8e9 --><!-- begin field 00c39c85-31ab-42b9-9363-65f05d2dd1a7 --><ul><li><strong>If there is interruption to the full primary course of immunizations, complete it without delay</strong> (doses already given do not need to be repeated). For children younger than 1 year of age, this consists of:<ul><li>Three doses of diphtheria, tetanus, pertussis, polio, <em>Haemophilus influenzae</em> type B and hepatitis B vaccine (DTaP/IPV/Hib/HepB) spaced at least 4 weeks apart.<ul><li>If Hib has not been given as part of a primary course of immunizations and no other components are required, give three doses of Hib/MenC combined vaccine at monthly intervals.</li></ul></li><li>One dose of pneumococcal conjugate vaccine (PCV).</li><li>Two doses of meningococcal group B vaccine (MenB), spaced 8 weeks apart.<ul><li>Infants who do not attend for their routine appointment at 4 months of age and consequently miss the second dose of MenB vaccine should be offered the vaccine at the earliest opportunity or at their next visit to the practice.</li></ul></li><li>Two doses of rotavirus vaccine spaced 4 weeks apart.<ul><li>The first dose of rotavirus vaccine should only be given to children older than 6 weeks and younger than 15 weeks old and the second dose should only be given to infants younger than 24 weeks old to minimize the risk of bowel intussusception.</li></ul></li></ul></li><li><strong>For the latest information on catch-up recommendations</strong><strong>,</strong> see the <a href=\"https://www.gov.uk/government/collections/immunisation\" data-hyperlink-id=\"f733465c-3e1a-4ca9-8df8-a8f7014c4d75\">Information for immunisation practitioners and other health professionals</a> from Public Health England (PHE). </li><li><strong>For an algorithm outlining the requirements for children who have missed vaccination doses,</strong> see the PHE document <a href=\"https://www.gov.uk/government/publications/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status\" data-hyperlink-id=\"0b62f865-c486-4fd2-b4a5-a8f7014c4dae\">Vaccination of individuals with uncertain or incomplete immunisation status</a>.</li></ul><!-- end field 00c39c85-31ab-42b9-9363-65f05d2dd1a7 --><!-- end item 0a909ee8-a5e1-4926-8751-bdebb9e2b8e9 -->","subChapters":[{"id":"9398457e-0eb8-5cc8-a900-98773ccb9b45","slug":"basis-for-recommendation-bc5","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a8ae8052-679f-4460-b1f7-6364afb9b3e2 --><h4>Basis for recommendation</h4><!-- end field a8ae8052-679f-4460-b1f7-6364afb9b3e2 -->","summary":null,"htmlStringContent":"<!-- begin item bc507064-ea5a-4f56-975b-541d0ec28870 --><!-- begin field 3363316e-157e-48bf-b386-45e3e71e1a43 --><p>These recommendations are based on the Public Health England documents <em>Routine childhood immunisations </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016e</a>], <em>The routine immunisation schedule </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016g</a>], <em>Vaccination of individuals with uncertain or incomplete immunisation status,</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016h</a>] and The hexavalent DTap/ipv/hIB/HepB combination vaccine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2017</a>]. </p><ul><li>In the chapter entitled <em>The UK immunisation schedule</em>, the 'Green Book' states that 'if any course of immunisation is interrupted, it should be resumed and completed as soon as possible. There is generally no need to start any course of immunisation again' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2014d</a>].</li></ul><h5>Meningococcal group B (MenB) vaccine</h5><ul><li>The recommendation on when to give a delayed second dose of MenB vaccine is based on the PHE document <em>Immunisation against meningococcal B disease for infants aged from two months. Information for healthcare professionals</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016f</a>].</li></ul><h5>Rotavirus vaccine</h5><ul><li>The recommendation regarding the age limits of the rotavirus vaccine is based on the chapter on rotavirus in <em>Immunisation against infectious disease</em> (the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015f</a>].</li></ul><!-- end field 3363316e-157e-48bf-b386-45e3e71e1a43 --><!-- end item bc507064-ea5a-4f56-975b-541d0ec28870 -->","subChapters":[]}]},{"id":"f698a4d5-7fef-5bbd-af9c-ed93213f9279","slug":"unknown-immunization-history","fullItemName":"Unknown immunization history","depth":3,"htmlHeader":"<!-- begin field f94e709b-4a25-4703-a1d1-776c24cc6c57 --><h3>What should I do if a child younger than 1 year of age has not been immunized or has an unknown immunization status?</h3><!-- end field f94e709b-4a25-4703-a1d1-776c24cc6c57 -->","summary":null,"htmlStringContent":"<!-- begin item f4fada59-cf9c-4cfd-9b3e-68d38307bc22 --><!-- begin field 481aa7ab-f7ec-4028-8b28-317eb2cba1e3 --><ul><li><strong>Plan to provide catch-up vaccinations to ensure protection quickly</strong> (with the minimum number of visits in the shortest possible timescale).</li><li><strong>If the child presents without a reliable immunization history, attempt to clarify what vaccines they have had wherever possible. </strong><ul><li>Children born outside the UK may have received some or all of the vaccinations that would be expected in the UK. For further information, see the <a href=\"http://apps.who.int/immunization_monitoring/globalsummary\" data-hyperlink-id=\"39d75f74-5a7e-4ba0-a131-a8f7014edafa\">country by country guide to immunization</a> from the World Health Organization.</li><li>If the primary course has been started but not completed, it should be continued. There is no need to repeat doses. For more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-childhood/management/children-up-to-1-year-of-age/#missed-doses\">Missed doses</a>.</li></ul></li><li><strong>If the history cannot be clarified, assume that the child has not been vaccinated.</strong> Give the following vaccinations (to be completed before the age of 1 year):<ul><li>Three doses of diphtheria, tetanus, pertussis, poliomyelitis, <em>Haemophilus influenzae</em> type b and hepatitis B vaccine (DTaP/IPV/Hib/HepB) spaced 4 weeks apart.</li><li>One dose of pneumococcal conjugate vaccine (PCV).</li><li>Two doses of meningococcal group B (Men B) vaccine, ideally spaced eight weeks apart.<ul><li>MenB can be given one month apart to ensure the immunization schedule is completed (for example when it is started at 10 months old).</li></ul></li><li>Two doses of rotavirus vaccine spaced 4 weeks apart.<ul><li>The first dose of rotavirus vaccine should only be given to children older than 6 weeks and younger than 15 weeks old and the second dose should only be given to infants younger than 24 weeks old to minimize the risk of bowel intussusception.</li></ul></li></ul></li><li><strong>Give boosters and subsequent vaccinations following the <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-childhood/background-information/the-routine-childhood-immunization-schedule/\">UK routine immunization schedule</a>.</strong><ul><li>Leave at least one month between DTaP/IPV/Hib/HepB doses and two months between MenB doses (for example if the primary course is started close to the child's first birthday).</li></ul></li><li>For an algorithm outlining the requirements for children who have not been immunized or have an unknown immunization status, see the Public Health England document <a href=\"https://www.gov.uk/government/publications/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status\" data-hyperlink-id=\"54480687-5b30-4fd1-9f29-a8f7014edb12\">Vaccination of individuals with uncertain or incomplete immunisation status</a>.</li></ul><!-- end field 481aa7ab-f7ec-4028-8b28-317eb2cba1e3 --><!-- end item f4fada59-cf9c-4cfd-9b3e-68d38307bc22 -->","subChapters":[{"id":"533bf54f-8701-5bd6-909d-a82b2015fc93","slug":"basis-for-recommendation-30a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d7c3a92b-507d-40e9-a644-14aae67b501d --><h4>Basis for recommendation</h4><!-- end field d7c3a92b-507d-40e9-a644-14aae67b501d -->","summary":null,"htmlStringContent":"<!-- begin item 30a373fb-2d72-487f-807c-64806baba611 --><!-- begin field 53adfbfe-f70b-41ec-801d-91d097d1269c --><p>These recommendations are based on the chapter on the UK immunization schedule in <em>Immunisation against infectious disease</em> (the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2014d</a>]; the guideline <em>Vaccination of individuals with uncertain or incomplete immunisation status </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016h</a>]; and summaries of the routine immunization schedule [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016e</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016g</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2017</a>] all published by Public Health England.</p><ul><li>The recommendations on the rotavirus vaccine are based on the chapter on rotavirus in <em>Immunisation against infectious disease</em> (the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015f</a>].</li></ul><!-- end field 53adfbfe-f70b-41ec-801d-91d097d1269c --><!-- end item 30a373fb-2d72-487f-807c-64806baba611 -->","subChapters":[]}]},{"id":"750f77cb-5889-52c7-bf04-5f92f49870d1","slug":"administering-the-vaccine","fullItemName":"Administering the vaccine","depth":3,"htmlHeader":"<!-- begin field 2101a8e0-184b-41a5-b07a-67cc9a433d1c --><h3>How should I administer vaccines in a child under 1 year of age?</h3><!-- end field 2101a8e0-184b-41a5-b07a-67cc9a433d1c -->","summary":null,"htmlStringContent":"<!-- begin item 4ac4e1c3-91a7-44e6-9699-e4f85b10c4a4 --><!-- begin field 267d2e72-2a0b-46ea-9e27-a767a81b8be6 --><ul><li><strong>Obtain written or verbal consent from a person with parental responsibility</strong> at the time of vaccination.</li><li><strong>Ensure that:</strong> <ul><li>There are no contraindications to the vaccine (for example, the presence of significant immunosuppression before administering live attenuated vaccines).</li><li>The parent or carer has been <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-childhood/management/children-up-to-1-year-of-age/#advice-for-parents\">fully informed</a> about the vaccine and the vaccination procedure.</li><li>Possible adverse effects have been discussed and the parent or carer is aware of how to manage them. Offer written information, for example the leaflet <a href=\"https://www.gov.uk/government/publications/what-to-expect-after-vaccinations\" data-hyperlink-id=\"5300634f-781f-49be-a6c2-a8f70154a080\">What to expect after vaccinations</a> published by Public Health England.</li></ul></li><li><strong>Check that the vaccine is correct, has been stored appropriately, and has not expired. </strong></li><li><strong>When administering the vaccine:</strong><ul><li>Wash the site with soap and water if it is visibly dirty. </li><li>Most vaccines are given by intramuscular (IM) injection. If the child has a bleeding disorder, use the subcutaneous (SC) route for vaccines normally given by the IM route as this reduces the risk of bleeding. <ul><li>Use a 25mm 23-gauge (blue) or 25-gauge (orange) needle for IM administration (a 16mm 25G needle may be appropriate for preterm or very small infants).</li><li>Give IM and SC immunizations into the anterolateral aspect of the thigh. Give MenB vaccine (Bexsero®) in the left thigh, ideally on its own. If an additional vaccine is required on the same day, use separate legs if possible, or inject at sites at least 2.5 cm apart.</li><li>Do not give immunizations into the buttock. </li></ul></li><li>Rotavirus vaccine (Rotarix®) is given orally.<ul><li>To administer the vaccine, seat the child in a reclining position and administer the entire contents of the oral applicator into the child’s mouth (towards the inner cheek).</li><li>If the baby spits out or regurgitates most of the vaccine, another single dose can be given (at the same visit). </li></ul></li><li>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</li></ul></li><li><strong>Observe the child after vaccination</strong> to detect immediate adverse effects. Ensure any bleeding has stopped, and check for any symptoms of anaphylaxis before they leave the premises.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field 267d2e72-2a0b-46ea-9e27-a767a81b8be6 --><!-- end item 4ac4e1c3-91a7-44e6-9699-e4f85b10c4a4 -->","subChapters":[{"id":"db99753e-1f0a-5c34-b224-f96fe67fabe5","slug":"basis-for-recommendation-ed4","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 939a05c0-e840-494b-9e13-f8a69cc64c52 --><h4>Basis for recommendation</h4><!-- end field 939a05c0-e840-494b-9e13-f8a69cc64c52 -->","summary":null,"htmlStringContent":"<!-- begin item ed43e07b-ed41-4461-9930-487a77983d90 --><!-- begin field 3f2e0e81-6b48-46d7-b35d-703acd9650b0 --><p>These recommendations are based on chapters in <em>Immunisation against infectious disease</em> (the 'Green Book') published by Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013m</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013n</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>] and what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013m</a>].</li></ul><h5>Site of administration</h5><ul><li>The site of administration depends on the child's age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013n</a>]:<ul><li>The anterolateral aspect of the thigh is appropriate in children younger than 1 year of age as the deltoid muscle is not considered to be sufficiently developed for intramuscular injection. The gluteal muscle should be avoided because the needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve.</li><li>PHE recommends that Bexsero<sup>®</sup> is administered in the left thigh, ideally on its own, to enable accurate monitoring and reporting of local adverse reactions. Bexsero<sup>®</sup> is a new vaccine and is being monitored under the Medicines and Healthcare products Regulatory Agency (MHRA) black triangle scheme [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016f</a>]. </li></ul></li></ul><h5>Administering the oral rotavirus vaccine</h5><ul><li>The recommendations on the oral rotavirus vaccine are based on the chapter on rotavirus in <em>Immunisation against infectious disease</em> (the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015f</a>].</li></ul><!-- end field 3f2e0e81-6b48-46d7-b35d-703acd9650b0 --><!-- end item ed43e07b-ed41-4461-9930-487a77983d90 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}